Kathleen Jaeger, J.D., R.Ph., CEO of MEDSECUREAN, has been a builder at three national trade associations that address our nation's most critical public health needs. She has helped transform two sectors of the healthcare system by ensuring Americans' access to affordable medicine and greater access to care, which have provided more opportunities for better community health along with corporate sustainability.
Over the years, Jaeger has served as the highly visible public face of accessible patient care, including testifying before Congress and engaging in stakeholder forums from the White House to think tanks. She also served as the spokesperson before critical constituencies, including with Wall Street analysts; corporations, trade associations, and earned media --CNN, Fox News, CNBC, NBC News, Wall Street Journal, New York Times, Washington Post, Boston Globe, Chicago Tribune, Los Angeles Times, PBS, NPR, and local television and radio stations.
As a proven dynamic leader and strategist, Mass Market Retailers magazine cited Jaeger as one of the Top 50 Most Influential Women in the Retail Industry for several years. The Wall Street Journal noted that Kathleen has a "flair for making lawmakers understand the nuances" of healthcare policy and patent law. CEO Update magazine called Jaeger a "top advocate" in Washington D.C. and selected her as a "Top Leader in Associations."
Jaeger was the Senior Vice President of Health and Wellness Strategy, Policy, and Patient Advocacy at the National Association of Chain Drug Stores (NACDS). Most recently, she played a pivotal role in the industry's COVID-19 response and recovery efforts, successfully addressing the many public policies, testing, and vaccination issues. Jaeger's leadership was instrumental in decisions by federal and state governments to make NACDS' 44,000 community pharmacies a centerpiece of the nation's COVID-19 response and recovery strategy, resulting in more than 300,000 million COVID vaccinations in pharmacy setting.
Jaeger also served as President of the NACDS Foundation since 2011, a 501(c)3 organization that operates to advance public health. She transformed the NACDS Foundation from a philanthropic enterprise into a research incubator for promising and sustainable innovative ways of care and improving the lives of patients and communities.
Jaeger further served for six years on the Board of Directors for Surescripts LLC, a national for-profit health information technology company. As the nation's single most trusted healthcare information network, Surescripts processes over 20 billion transactions a year, driving interoperability and transmission of health records and clinical and insurance data across health care stakeholders from health systems to clinicians.
Before joining NACDS, Kathleen served as President and CEO of the Generic Pharmaceutical Association for eight years and a partner in two national law firms' food and drug practices, Kirkpatrick & Lockhart, LLP, and McKenna & Cuneo, LLP.
She received the University of Rhode Island President's Distinguished Achievement Award in 2007. She served on the March of Dimes Finance Committee for the Congressional Gourmet Gala (2017-21); the Johns Hopkins Project RESTORE Board of Ambassadors (2009-10); Co-Chair for the National Organization of Rare Diseases Gala Event (2003-09); the Board of Healthcare Ready (2014-20); the Board of the American Foundation for Pharmaceutical Education (2008-21); the Board of the International Generic Pharmaceutical Alliance (2001-10); and the Board of the NGO, Cumvivium, sponsored by the Vatican, which aimed to remove global barriers that impeded affordable access medicines and facilitate distribution of affordable AIDS/HIV drugs to Africa (2002-05). Jaeger was a member of the U.S. Chamber of Commerce, C100 Group.